I migliori medici per il trattamento di Cancro al seno - TOP-171 medici

Oltre 900 interventi per il cancro al seno in 32 anni – Il Prof. Karagöz è specializzato in biologia dei tumori e immunoterapia presso l'Anadolu Medical Center.

• Professore di oncologia medica con oltre 40 pubblicazioni scientifiche
• Esperto in terapie mirate e immunoterapia del cancro
• Direttore di Oncologia Medica presso importanti ospedali turchi
• Membro dell'Associazione Turca di Oncologia Medica

Il Prof. Dr. Kemal Rasa è specializzato in chirurgia del cancro al seno presso l'Anadolu Medical Center, con 28 anni di esperienza e oltre 900 interventi eseguiti.

• Presidente della Surgical Infection Society - Europe
• Si concentra su interventi minimamente invasivi per il cancro al seno
• Membro di diverse prestigiose società chirurgiche, inclusa la WSES
• Docente presso il Dipartimento di Chirurgia Generale dell'Università di Hacettepe

Professoressa in oncologia presso l'Anadolu Medical Center. Ha ricoperto il ruolo di ricercatrice principale in numerosi studi clinici internazionali sul cancro al seno.

• Specializzata in oncologia medica e chemioterapia
• Ex responsabile dell'Unità di Oncologia Medica presso l'ospedale di formazione e ricerca Haydarpaşa Numune
• Ha completato la sua formazione in oncologia medica presso l'Università di Marmara, uno dei migliori programmi della Turchia

Il Prof. Associato Mustafa Solak ha eseguito oltre 1.100 trattamenti, specializzandosi nel carcinoma mammario presso l'Hisar Hospital Intercontinental.

• 19 anni di esperienza in oncologia clinica
• Formazione specialistica presso il Cancer Institute dell'Università Hacettepe
• Ha lavorato presso il MD Anderson Cancer Center dell'Università del Texas
• Specializzato in tumori mammari, ovarici e gastrointestinali

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

Oltre 30 anni al Sourasky Medical Center specializzato nel cancro al seno – il Dott. Merimsky è Professore Associato ed ex Presidente di Oncologia.

• Esperienza di ricerca estesa nell'immunologia tumorale presso il Felsenstein Medical Research Center
• Tesi di dottorato pubblicata sul carcinoma lobulare in situ
• Fellowship nei sarcomi dei tessuti molli e delle ossa presso l'Institut Gustave Roussy, Parigi
• Membro attivo di ESMO e ASCO con numerose partecipazioni a conferenze

Il medico è specializzato in ginecologia oncologica e radioterapia, concentrandosi sul trattamento e la gestione dei tumori ginecologici. Con un'ampia esperienza nelle tecniche avanzate di radioterapia, il medico ha contribuito a migliorare i risultati dei pazienti attraverso approcci innovativi nella cura del cancro. Il medico è riconosciuto per il suo impegno nell'integrare la ricerca all'avanguardia nella pratica clinica, garantendo che i pazienti ricevano i trattamenti più efficaci e aggiornati disponibili.<\/p>

Responsabile del Centro per il Cancro al Seno presso la Clinica di Solingen – Il Dott. Seifert è specializzato in interventi chirurgici conservativi del seno e ricostruzione estetica.

• Oltre 20 anni di esperienza in ginecologia e salute del seno
• Esperto in tecniche di conservazione dell'organo per il cancro al seno
• Guida diagnostiche complete, inclusa la mammografia 3D e la risonanza magnetica
• Fornisce opzioni di ricostruzione plastica post-operatoria
• Offre supporto psicologico durante tutto il trattamento

Il medico è un praticante altamente esperto presso il Sourasky Medical Center, specializzato in Medicina Interna e Cardiologia. Con oltre 20 anni di esperienza, il medico è certificato in entrambi i campi. Il focus clinico include Cardiologia, Pneumologia e Medicina Critica, fornendo cure complete per una vasta gamma di malattie e condizioni.<\/p>

14 anni di specializzazione in radioterapia – Il Dr. Asawadech Sanbua pianifica con competenza trattamenti 2D, 3D, IMRT e VMAT presso il Panacee Hospital Rama2.

• 5 anni di utilizzo di macchine per oncothermia – una terapia di ipertermia mirata
• Oltre 900 trattamenti oncologici eseguiti
• Certificato in terapia Oncotherm
• 18 anni di esperienza medica

Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.

He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.